Product Images Acyclovir

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Acyclovir NDC 71205-578 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71205-578-30 - 6144211401

71205-578-30 - 6144211401

This is a description of Acyclovir, a prescription drug that comes in the form of capsules containing 200mg of Acyclovir USP. It is packaged by Proficent Rx LP with the product ID QA057830. Each capsule is an oval shape, and has an opaque light blue cap imprinted with the number "200" and an aqua blue opaque body imprinted with the letters "CTI" over "114". The lot number is mentioned as 00000, and the expiration date is 00/00/00. The product is intended for use by individuals with a valid prescription only, and should be kept out of the reach of children.*

Structural Formula - acy03 0000 01

Structural Formula - acy03 0000 01

Table 1 - acy03 0000 02

Table 1 - acy03 0000 02

Table 1 provides pharmacokinetic features of Acyclovir including plasma protein binding, plasma elimination half-life, and average oral bioavailability. The range of values is given for each parameter. The plasma protein binding ranges from 9% to 1033%, while the half-life of plasma elimination ranges from 25 to 1033 hours. The average oral bioavailability ranges from 10% to 20%, with a decrease in bioavailability observed for higher doses.*

Table 2 - acy03 0000 03

Table 2 - acy03 0000 03

This text provides the Acyclovir peak and trough concentrations at a steady-state for three different dosages: 200mg, 400mg, and 800mg. The concentrations are given in meg/mL.*

Table 3 - acy03 0000 04

Table 3 - acy03 0000 04

Table 3 shows the adjusted dosage regimen for individuals suffering from renal impairment. The table contains information on the normal dosage, creatinine clearance, and adjusted dosage regimen. The adjusted dosage regimen is based on the severity of the impairment and ranges from 200 mg to 800 mg, administered every 4 to 12 hours. Dosage is adjusted depending on the patient's creatinine clearance levels.*

Imprint CTI 114 - acy03 0000 05

Imprint CTI 114 - acy03 0000 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.